The prevalence of proviral bovine leukemia virus in peripheral blood mononuclear cells at two subclinical stages of infection.
about
Mechanisms of leukemogenesis induced by bovine leukemia virus: prospects for novel anti-retroviral therapies in humanMechanisms of pathogenesis induced by bovine leukemia virus as a model for human T-cell leukemia virusDiscordance between bovine leukemia virus tax immortalization in vitro and oncogenicity in vivo.Low numbers of intestinal Shiga toxin-producing E. coli correlate with a poor prognosis in sheep infected with bovine leukemia virusHematopoietic stem cells and retroviral infection.Bovine leukemia virus-induced lymphocytosis and increased cell survival mainly involve the CD11b+ B-lymphocyte subset in sheep.Prostaglandin E(2) increases bovine leukemia virus tax and pol mRNA levels via cyclooxygenase 2: regulation by interleukin-2, interleukin-10, and bovine leukemia virus.Bovine leukemia virus structural gene vectors are immunogenic and lack pathogenicity in a rabbit model.Regulation of bovine leukemia virus tax and pol mRNA levels by interleukin-2 and -10.Assessment of bovine leukemia virus transcripts in vivo.CD154 costimulated ovine primary B cells, a cell culture system that supports productive infection by bovine leukemia virusAntiviral activity of shiga toxin 1: suppression of bovine leukemia virus-related spontaneous lymphocyte proliferationAntiviral activity of shiga toxin requires enzymatic activity and is associated with increased permeability of the target cellsIntestinal Shiga toxin-producing Escherichia coli bacteria mitigate bovine leukemia virus infection in experimentally infected sheep.Estimation of bovine leukemia virus (BLV) proviral load harbored by lymphocyte subpopulations in BLV-infected cattle at the subclinical stage of enzootic bovine leucosis using BLV-CoCoMo-qPCR.Dissemination of bovine leukemia virus-infected cells from a newly infected sheep lymph nodeSequencing and phylogenetic analysis of the gp51 gene from Korean bovine leukemia virus isolates.In vivo study of genetically simplified bovine leukemia virus derivatives that lack tax and rexShiga toxin 1 targets bovine leukemia virus-expressing cells.Serological and molecular detection of bovine leukemia virus in cattle in Iraq.Development and evaluation of an immunochromatographic assay using a gp51 monoclonal antibody for the detection of antibodies against the bovine leukemia virus.Immune exhaustion during chronic infections in cattle.Bovine leukemia virus reduces anti-viral cytokine activities and NK cytotoxicity by inducing TGF-β secretion from regulatory T cells.B-lymphocyte proliferation during bovine leukemia virus-induced persistent lymphocytosis is enhanced by T-lymphocyte-derived interleukin-2.Dairy Cows Naturally Infected with Bovine Leukemia Virus Exhibit Abnormal B- and T-Cell Phenotypes after Primary and Secondary Exposures to Keyhole Limpet Hemocyanin.Epidemiology and genetic diversity of bovine leukemia virus.Intrauterine infection with bovine leukemia virus in pregnant dam with high viral load.Genome-wide scan for commons SNPs affecting bovine leukemia virus infection level in dairy cattle.Inter-laboratory comparison of six real time polymerase chain reaction assays for detection of bovine leukemia virus proviral DNA.Cooperation of PD-1 and LAG-3 in the exhaustion of CD4+ and CD8+ T cells during bovine leukemia virus infection.Bovine Leukemia Virus Infection in Neonatal Calves. Risk Factors and Control Measures
P2860
Q21245197-185CC4A5-1025-45B4-B725-843FE9AFFCEBQ26863681-EA318CF5-E3FE-4690-A318-FD773253F4B0Q33603462-B5ED1111-2F59-4561-A958-1A05F187A33DQ33612110-57831C6E-6771-4094-9799-8B1E3173AFD4Q33677922-8D5BC8A7-CCBF-4033-9D0B-E3413725DCC1Q33782898-AC506586-55C2-4EBD-97A9-0E04CB24EFD2Q33806129-9515B675-D197-4ADE-86A0-D746E14F7359Q33819351-1D21E580-0073-4CD9-8A40-EB37473AE5E8Q33820243-342184D6-16D8-47FA-9656-CF55800DEC3BQ33821772-C49C5FE4-EB39-4EA7-AB99-500EDF3DF78BQ33836014-C3855612-354E-460F-ADAB-6A75866268A5Q34007607-DA7F253B-AB55-4B6E-8EAC-1653BB54E28CQ34531637-22DA5352-F8FD-48F2-93A0-941DAA68BE1FQ34601837-A9A0CBC7-E036-408B-BE0D-C1EAA646F38BQ34704549-7D80ACBE-975D-452B-BE18-96565085D53DQ35023974-6DFAC14A-EBD5-4022-8439-8E597C2D7B71Q35519381-1F9219E5-65E5-4B58-9B06-64EB0DC6CD0CQ35877433-AB9DE091-E60D-4F5B-B199-0BAE8C7DE160Q36575980-60931F3B-3163-4AAA-AB48-F0DB1174B022Q37064301-A2ADA7AF-7F4C-448D-BD60-A6D0B681CD3EQ37547874-5D8DAF70-03DC-4162-AA43-433F15EDD666Q37621297-FA7F35CE-A34C-4016-BD56-4F0353FF5186Q38638547-2FDCC862-E35B-407B-ACE7-542862D2AE98Q39579254-2E798E8D-B70C-457E-A3B9-B19788BFEE23Q40097117-BBBE88E1-BAA6-4B6C-939C-E81F203290BFQ44005820-57570D51-DBBF-4C6B-A911-CBDD1A463916Q45325214-A8B11CDB-B7A1-44C1-86D8-460E4A9CBD4AQ49232096-F0C04960-4D6F-4395-91B4-EE0D76C9B21BQ54233019-B0CA0F84-3654-43A6-89EF-D095106B87F0Q55347066-9EBDF27B-FF8F-4706-A937-E644454AD255Q58556868-A6D03DF5-B711-4D94-87C4-860AAFDE3479
P2860
The prevalence of proviral bovine leukemia virus in peripheral blood mononuclear cells at two subclinical stages of infection.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
The prevalence of proviral bov ...... bclinical stages of infection.
@ast
The prevalence of proviral bov ...... bclinical stages of infection.
@en
type
label
The prevalence of proviral bov ...... bclinical stages of infection.
@ast
The prevalence of proviral bov ...... bclinical stages of infection.
@en
prefLabel
The prevalence of proviral bov ...... bclinical stages of infection.
@ast
The prevalence of proviral bov ...... bclinical stages of infection.
@en
P2093
P2860
P1433
P1476
The prevalence of proviral bov ...... ubclinical stages of infection
@en
P2093
P2860
P304
P407
P577
1996-04-01T00:00:00Z